Amit Kumar

Insider · Chief Executive Officer · ANIX

Amit Kumar files insider transactions with the SEC as a chief executive officer of Anixa Biosciences (ANIX). We hold 7 disclosed purchases and sales filed since 20 July 2006, 7 of them in the last 90 days.

Files forANIX
Disclosed buys and sells7 in all, 7 in the last 90 days
Last disclosure3 August 2026

Positions held

9 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 25 October 2018 — 31 July 2026Chief Executive Officer · Anixa Biosciences (ANIX)58 Form 4 lines · source: SEC Form 4
Filed 5 February 2015 — 14 September 2018Chief Executive Officer · Itus (ITUS)51 Form 4 lines · source: SEC Form 4
Filed 1 July 2008 — 19 May 2016Director · Ascent Solar Technologies (ASTI)38 Form 4 lines · source: SEC Form 4
Filed 12 September 2006 — 1 October 2015Director · Aeolus Pharmaceuticals (AOLS)38 Form 4 lines · source: SEC Form 4
Filed 26 June 2015 — 6 July 2015Director · Itus (ITUSD)4 Form 4 lines · source: SEC Form 4
Filed 25 January 2013 — 15 July 2014Director · Copytele (COPY)44 Form 4 lines · source: SEC Form 4
Filed 17 September 2007 — 3 January 2012President and CEO · CombiMatrix (CBMX)56 Form 4 lines · source: SEC Form 4
Filed 15 August 2007 — 15 August 2007President & CEO · CombiMatrix (CBMXD)2 Form 4 lines · source: SEC Form 4
Filed 18 July 2006 — 4 May 2007Pres/CEO of CombiMatrix Corp. · Acacia Research (ACTG/CBMX)27 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

▲ bought on the open market 5,000 shares of Anixa BiosciencesSEC Form 43 August 2026Common Stock · traded 31 July 2026 · filed 3 August 2026
▲ bought on the open market 5,000 shares of Anixa BiosciencesSEC Form 428 July 2026Common Stock · traded 27 July 2026 · filed 28 July 2026
▲ bought on the open market 3,000 shares of Anixa BiosciencesSEC Form 427 July 2026Common Stock · traded 24 July 2026 · filed 27 July 2026
▲ bought on the open market 3,188 shares of Anixa BiosciencesSEC Form 427 July 2026Common Stock · traded 27 July 2026 · filed 27 July 2026
▲ bought on the open market 5,000 shares of Anixa BiosciencesSEC Form 421 July 2026Common Stock · traded 20 July 2026 · filed 21 July 2026
▲ bought on the open market 5,000 shares of Anixa BiosciencesSEC Form 413 July 2026Common Stock · traded 10 July 2026 · filed 13 July 2026
▲ bought on the open market 21,000 shares of Anixa BiosciencesSEC Form 416 June 2026Common Stock · traded 12 June 2026 · filed 16 June 2026
was granted 350,000 shares of Anixa Biosciences (a derivative holding)SEC Form 46 January 2026Employee Stock Option · traded 5 January 2026 · filed 6 January 2026
was granted 350,000 shares of Anixa Biosciences (a derivative holding)SEC Form 46 January 2026Employee Stock Option · traded 5 January 2026 · filed 6 January 2026
exercised options over 200,000 shares of Anixa Biosciences (a derivative holding)SEC Form 431 October 2025Employee Stock Option (Right to Buy) · traded 30 October 2025 · filed 31 October 2025
exercised options over 200,000 shares of Anixa BiosciencesSEC Form 431 October 2025Common Stock · traded 30 October 2025 · filed 31 October 2025
had shares withheld for tax on 169,439 shares of Anixa BiosciencesSEC Form 431 October 2025Common Stock · traded 30 October 2025 · filed 31 October 2025
▲ bought on the open market 5,000 shares of Anixa BiosciencesSEC Form 431 July 2025Common Stock · traded 30 July 2025 · filed 31 July 2025
▲ bought on the open market 5,000 shares of Anixa BiosciencesSEC Form 414 July 2025Common Stock · traded 11 July 2025 · filed 14 July 2025
▲ bought on the open market 10,000 shares of Anixa BiosciencesSEC Form 45 June 2025Common Stock · traded 4 June 2025 · filed 5 June 2025
▲ bought on the open market 43,000 shares of Anixa BiosciencesSEC Form 415 January 2025Common Stock · traded 15 January 2025 · filed 15 January 2025
was granted 700,000 shares of Anixa Biosciences (a derivative holding)SEC Form 43 January 2025Employee Stock Option · traded 2 January 2025 · filed 3 January 2025
▲ bought on the open market 25,000 shares of Anixa BiosciencesSEC Form 47 June 2024Common Stock · traded 7 June 2024 · filed 7 June 2024
▲ bought on the open market 30,000 shares of Anixa BiosciencesSEC Form 415 March 2024Common Stock · traded 15 March 2024 · filed 15 March 2024
was granted 700,000 shares of Anixa Biosciences (a derivative holding)SEC Form 416 January 2024Employee Stock Option (Right to Buy) · traded 12 January 2024 · filed 16 January 2024
exercised options over 40,000 shares of Anixa Biosciences (a derivative holding)SEC Form 431 July 2023Employee Stock Option (Right to Buy) · traded 28 July 2023 · filed 31 July 2023
exercised options over 40,000 shares of Anixa BiosciencesSEC Form 431 July 2023Common Stock · traded 28 July 2023 · filed 31 July 2023
had shares withheld for tax on 28,375 shares of Anixa BiosciencesSEC Form 431 July 2023Common Stock · traded 28 July 2023 · filed 31 July 2023
▼ sold on the open market 11,800 shares of Anixa BiosciencesSEC Form 431 July 2023Common Stock · traded 31 July 2023 · filed 31 July 2023
was granted 700,000 shares of Anixa Biosciences (a derivative holding)SEC Form 44 January 2023Employee Stock Option (Right to Buy) · traded 3 January 2023 · filed 4 January 2023
exercised options over 640,000 shares of Anixa Biosciences (a derivative holding)SEC Form 416 September 2022Employee Stock Option (Right to Buy) · traded 15 September 2022 · filed 16 September 2022
exercised options over 640,000 shares of Anixa BiosciencesSEC Form 416 September 2022Common Stock · traded 15 September 2022 · filed 16 September 2022
had shares withheld for tax on 491,900 shares of Anixa BiosciencesSEC Form 416 September 2022Common Stock · traded 15 September 2022 · filed 16 September 2022
was granted 500,000 shares of Anixa Biosciences (a derivative holding)SEC Form 411 March 2022Employee Stock Option (Right to Buy) · traded 10 March 2022 · filed 11 March 2022
▲ bought on the open market 20,000 shares of Anixa BiosciencesSEC Form 47 January 2022Common Stock · traded 7 January 2022 · filed 7 January 2022
▲ bought on the open market 2,000 shares of Anixa BiosciencesSEC Form 41 November 2021Common Stock · traded 29 October 2021 · filed 1 November 2021
▲ bought on the open market 5,000 shares of Anixa BiosciencesSEC Form 427 July 2021Common Stock · traded 23 July 2021 · filed 27 July 2021
▲ bought on the open market 10,000 shares of Anixa BiosciencesSEC Form 420 July 2021Common Stock · traded 16 July 2021 · filed 20 July 2021
was granted 2,000,000 shares of Anixa Biosciences (a derivative holding)SEC Form 42 June 2021Employee Stock Option (Right to Buy) · traded 1 June 2021 · filed 2 June 2021
was granted 500,000 shares of Anixa Biosciences (a derivative holding)SEC Form 42 June 2021Employee Stock Option (Right to Buy) · traded 1 June 2021 · filed 2 June 2021
returned to the issuer 1,500,000 shares of Anixa Biosciences (a derivative holding)SEC Form 42 June 2021Restricted Stock Award · traded 31 May 2021 · filed 2 June 2021
▲ bought on the open market 5,000 shares of Anixa BiosciencesSEC Form 425 March 2021Common Stock · traded 25 March 2021 · filed 25 March 2021
▲ bought on the open market 10,000 shares of Anixa BiosciencesSEC Form 41 February 2021Common Stock · traded 29 January 2021 · filed 1 February 2021
was granted 1,000,000 shares of Anixa Biosciences (a derivative holding)SEC Form 428 December 2020Employee Stock Option (Right to Buy) · traded 23 December 2020 · filed 28 December 2020
▲ bought on the open market 28,000 shares of Anixa BiosciencesSEC Form 411 September 2020Common Stock · traded 11 September 2020 · filed 11 September 2020
▲ bought on the open market 20,000 shares of Anixa BiosciencesSEC Form 412 June 2020Common Stock · traded 12 June 2020 · filed 12 June 2020
▲ bought on the open market 20,000 shares of Anixa BiosciencesSEC Form 412 March 2020Common Stock · traded 12 March 2020 · filed 12 March 2020
▲ bought on the open market 20,000 shares of Anixa BiosciencesSEC Form 414 January 2020Common Stock · traded 14 January 2020 · filed 14 January 2020
was granted 520,000 shares of Anixa Biosciences (a derivative holding)SEC Form 416 December 2019Employee Stock Option (Right to Buy) · traded 12 December 2019 · filed 16 December 2019
returned to the issuer 320,000 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
was granted 320,000 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
returned to the issuer 106,667 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
was granted 106,667 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
returned to the issuer 213,333 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
was granted 213,333 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
returned to the issuer 40,000 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
was granted 40,000 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
returned to the issuer 200,000 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
was granted 200,000 shares of Anixa Biosciences (a derivative holding)SEC Form 420 September 2019Employee Stock Option · traded 20 September 2019 · filed 20 September 2019
▲ bought on the open market 10,000 shares of Anixa BiosciencesSEC Form 416 September 2019Common Stock · traded 13 September 2019 · filed 16 September 2019
▲ bought on the open market 4,000 shares of Anixa BiosciencesSEC Form 429 April 2019Common Stock · traded 26 April 2019 · filed 29 April 2019
▲ bought on the open market 10,000 shares of Anixa BiosciencesSEC Form 424 April 2019Common Stock · traded 24 April 2019 · filed 24 April 2019
▲ bought on the open market 11,000 shares of Anixa BiosciencesSEC Form 425 October 2018Common Stock · traded 25 October 2018 · filed 25 October 2018
▲ bought on the open market 3,000 shares of ItusSEC Form 418 September 2018Common Stock · traded 14 September 2018 · filed 18 September 2018
▲ bought on the open market 3,000 shares of ItusSEC Form 414 September 2018Common Stock · traded 13 September 2018 · filed 14 September 2018
▲ bought on the open market 4,112 shares of ItusSEC Form 413 September 2018Common Stock · traded 13 September 2018 · filed 13 September 2018
▲ bought on the open market 4,480 shares of ItusSEC Form 412 September 2018Common Stock · traded 12 September 2018 · filed 12 September 2018
was granted 1,500,000 shares of Itus (a derivative holding)SEC Form 414 May 2018Restricted Stock Award · traded 8 May 2018 · filed 14 May 2018
was granted 600,000 shares of Itus (a derivative holding)SEC Form 414 May 2018Employee Stock Option · traded 8 May 2018 · filed 14 May 2018
was granted 1,500,000 shares of Itus (a derivative holding)SEC Form 414 May 2018Employee Stock Option · traded 8 May 2018 · filed 14 May 2018
returned to the issuer 320,000 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
was granted 320,000 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
returned to the issuer 106,667 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
was granted 106,667 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
returned to the issuer 213,333 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
was granted 213,333 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
returned to the issuer 40,000 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
was granted 40,000 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
returned to the issuer 200,000 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
was granted 200,000 shares of Itus (a derivative holding)SEC Form 48 September 2017Employee Stock Option · traded 6 September 2017 · filed 8 September 2017
▲ bought on the open market 10,000 shares of ItusSEC Form 46 June 2017Common Stock · traded 5 June 2017 · filed 6 June 2017
▲ bought on the open market 500 shares of ItusSEC Form 45 June 2017Common Stock · traded 2 June 2017 · filed 5 June 2017
▲ bought on the open market 1,422 shares of ItusSEC Form 45 June 2017Common Stock · traded 2 June 2017 · filed 5 June 2017
▲ bought on the open market 8,078 shares of ItusSEC Form 45 June 2017Common Stock · traded 2 June 2017 · filed 5 June 2017
was granted 566,664 shares of Ascent Solar TechnologiesSEC Form 423 May 2016Common Stock · traded 19 May 2016 · filed 23 May 2016
▲ bought on the open market 1,000 shares of ItusSEC Form 42 March 2016Common Stock · traded 29 February 2016 · filed 2 March 2016
▲ bought on the open market 1,000 shares of ItusSEC Form 42 March 2016Common Stock · traded 1 March 2016 · filed 2 March 2016
was granted 200,000 shares of Itus (a derivative holding)SEC Form 419 February 2016Employee Stock Options (Right to Buy) · traded 18 February 2016 · filed 19 February 2016
was granted 100,000 shares of Aeolus Pharmaceuticals (a derivative holding)SEC Form 43 February 2016Non-qualified Stock Option (right to buy) · traded 1 October 2013 · filed 3 February 2016
was granted 100,000 shares of Aeolus Pharmaceuticals (a derivative holding)SEC Form 43 February 2016Non-qualified Stock Option (right to buy) · traded 1 October 2014 · filed 3 February 2016
was granted 100,000 shares of Aeolus Pharmaceuticals (a derivative holding)SEC Form 43 February 2016Non-qualified Stock Option (right to buy) · traded 1 October 2015 · filed 3 February 2016
was granted 200,000 shares of Ascent Solar TechnologiesSEC Form 45 January 2016Common Stock · traded 1 January 2016 · filed 5 January 2016
▲ bought on the open market 1,000 shares of ItusSEC Form 429 September 2015Common Stock · traded 25 September 2015 · filed 29 September 2015
▲ bought on the open market 1,500 shares of ItusSEC Form 43 August 2015Common Stock · traded 30 July 2015 · filed 3 August 2015
▲ bought on the open market 1,500 shares of ItusSEC Form 428 July 2015Common Stock · traded 24 July 2015 · filed 28 July 2015
▲ bought on the open market 5,000 shares of ItusSEC Form 423 July 2015Common Stock · traded 21 July 2015 · filed 23 July 2015
▲ bought on the open market 1,000 shares of ItusSEC Form 421 July 2015Common Stock · traded 17 July 2015 · filed 21 July 2015
▲ bought on the open market 1,000 shares of ItusSEC Form 421 July 2015Common Stock · traded 20 July 2015 · filed 21 July 2015
▲ bought on the open market 3,500 shares of ItusSEC Form 48 July 2015Common Stock · traded 6 July 2015 · filed 8 July 2015
▲ bought on the open market 1,700 shares of ItusSEC Form 42 July 2015Common Stock · traded 30 June 2015 · filed 2 July 2015
▲ bought on the open market 2,000 shares of ItusSEC Form 41 July 2015Common Stock · traded 29 June 2015 · filed 1 July 2015
▲ bought on the open market 100 shares of ItusSEC Form 429 June 2015Common Stock · traded 26 June 2015 · filed 29 June 2015
▲ bought on the open market 50,000 shares of ItusSEC Form 424 June 2015Common Stock · traded 19 June 2015 · filed 24 June 2015
▲ bought on the open market 50,000 shares of ItusSEC Form 424 June 2015Common Stock · traded 22 June 2015 · filed 24 June 2015
▲ bought on the open market 50,000 shares of ItusSEC Form 423 June 2015Common Stock · traded 19 June 2015 · filed 23 June 2015
▲ bought on the open market 50,000 shares of ItusSEC Form 423 June 2015Common Stock · traded 22 June 2015 · filed 23 June 2015
▲ bought on the open market 100,000 shares of ItusSEC Form 419 June 2015Common Stock · traded 15 June 2015 · filed 19 June 2015
▲ bought on the open market 50,000 shares of ItusSEC Form 419 June 2015Common Stock · traded 17 June 2015 · filed 19 June 2015
▲ bought on the open market 50,000 shares of ItusSEC Form 411 June 2015Common Stock · traded 9 June 2015 · filed 11 June 2015
▲ bought on the open market 100,000 shares of ItusSEC Form 411 June 2015Common Stock · traded 10 June 2015 · filed 11 June 2015
▲ bought on the open market 25,000 shares of ItusSEC Form 411 June 2015Common Stock · traded 11 June 2015 · filed 11 June 2015
▲ bought on the open market 25,000 shares of ItusSEC Form 44 June 2015Common Stock · traded 4 June 2015 · filed 4 June 2015
▲ bought on the open market 50,000 shares of ItusSEC Form 42 June 2015Common Stock · traded 1 June 2015 · filed 2 June 2015
▲ bought on the open market 50,000 shares of ItusSEC Form 42 June 2015Common Stock · traded 2 June 2015 · filed 2 June 2015
▲ bought on the open market 15,000 shares of ItusSEC Form 48 April 2015Common Stock · traded 6 April 2015 · filed 8 April 2015
▲ bought on the open market 35,000 shares of ItusSEC Form 48 April 2015Common Stock · traded 6 April 2015 · filed 8 April 2015
▲ bought on the open market 113,000 shares of ItusSEC Form 416 March 2015Common Stock · traded 13 March 2015 · filed 16 March 2015
returned to the issuer 8,000,000 shares of Itus (a derivative holding)SEC Form 45 February 2015Employee Stock Option · traded 5 February 2015 · filed 5 February 2015
was granted 8,000,000 shares of Itus (a derivative holding)SEC Form 45 February 2015Employee Stock Option · traded 5 February 2015 · filed 5 February 2015
returned to the issuer 8,000,000 shares of Itus (a derivative holding)SEC Form 45 February 2015Employee Stock Option · traded 5 February 2015 · filed 5 February 2015
was granted 8,000,000 shares of Itus (a derivative holding)SEC Form 45 February 2015Employee Stock Option · traded 5 February 2015 · filed 5 February 2015
returned to the issuer 1,000,000 shares of Itus (a derivative holding)SEC Form 45 February 2015Employee Stock Option · traded 5 February 2015 · filed 5 February 2015
was granted 1,000,000 shares of Itus (a derivative holding)SEC Form 45 February 2015Employee Stock Option · traded 5 February 2015 · filed 5 February 2015
was granted 107,476 shares of Ascent Solar TechnologiesSEC Form 45 January 2015Common Stock · traded 1 January 2015 · filed 5 January 2015
▲ bought on the open market 100,000 shares of CopyteleSEC Form 417 July 2014Common Stock · traded 15 July 2014 · filed 17 July 2014

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.